Antibody Therapeutics for Life

Notices

Dr. Jin-San Yoo, CEO of PharmAbcine is joining for the ``Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology`` of Tumor Course of Harvard Medical School and for networking on September 5-8th, 2017.
  • Written by Admin
  • Written date 2019-01-14 11:29:35
  • Inquire 1048
Dr. Jin-San Yoo, CEO of PharmAbcine is joining for the "Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology" of Tumor Course of Harvard Medical School and for networking on September 5-8th, 2017.
List





Prev Dr. Jin-San Yoo, CEO of PharmAbcine and Dr. Sung Woo Kim, Head of Business Devel...
Next Dr. Jin-San Yoo, CEO of PharmAbcine is attending to THE 10TH COGNO ANNUAL SCIENT...